Stockreport

Immunocore announces 2026 strategic priorities at 44th Annual J.P. Morgan Healthcare Conference [Yahoo! Finance]

Immunocore Holdings plc - American Depositary Shares  (IMCR) 
PDF Reaching more metastatic uveal melanoma patients with KIMMTRAK (tebentafusp) in 2026 through US community and global market penetration Enrolling three Phase 3 trials [Read more]